Cable Hill Partners, LLC - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 156 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2017. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cable Hill Partners, LLC ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q3 2017$4,000
-20.0%
80
-2.4%
0.00%
-33.3%
Q2 2017$5,000
-16.7%
820.0%0.00%0.0%
Q1 2017$6,000
+100.0%
82
+127.8%
0.00%
+200.0%
Q4 2016$3,000
-50.0%
36
-59.1%
0.00%
-75.0%
Q3 2016$6,000
+100.0%
88
+54.4%
0.00%
+100.0%
Q2 2016$3,000
-25.0%
570.0%0.00%
-33.3%
Q1 2016$4,000
-42.9%
570.0%0.00%
-40.0%
Q4 2015$7,000
+16.7%
570.0%0.01%0.0%
Q3 2015$6,000570.01%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q3 2017
NameSharesValueWeighting ↓
Iguana Healthcare Management, LLC 75,000$4,658,0002.63%
COLUMBIA WANGER ASSET MANAGEMENT LLC 1,364,434$84,745,0001.21%
CAPITAL INTERNATIONAL LTD /CA/ 259,700$16,130,0001.07%
Aureus Asset Management, LLC 65,670$4,079,0000.69%
Capital International Sarl 124,320$7,722,0000.67%
CAPITAL GUARDIAN TRUST CO 512,430$31,827,0000.58%
ROCKEFELLER FINANCIAL SERVICES INC 408,379$25,365,0000.50%
Rock Springs Capital Management LP 160,500$9,969,0000.50%
Hood River Capital Management LLC 112,296$6,975,0000.48%
Capital International, Inc./CA/ 52,700$3,273,0000.47%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders